Stock market weekly wrap: Sensex, Nifty50 remained range-bound; What to expect from Indian stock market next week? | Stock Market News

Stock market weekly wrap: Sensex, Nifty50 remained range-bound; What to expect from Indian stock market next week? | Stock Market News

Source: Live Mint Indian stock market: Over the past week, the Indian stock market remained confined within a narrow range, culminating in a weekly loss. This downturn was primarily driven by escalating global trade tensions and substantial foreign capital outflows, which have dampened prospects for a sustained market recovery. On Thursday, the 30-share BSE Sensex…

Read More
Should you borrow to invest? The truth about taking a personal loan for stocks | Mint

Should you borrow to invest? The truth about taking a personal loan for stocks | Mint

Source: Live Mint The Indian stock market continues to remain volatile due to the ongoing geo-political issues such as: Trump’s tariff threat, Russia-Ukraine war, global inflation, high interest rates etc. All these issues have cumulatively resulted in India’s benchmark Nifty 50 index suffering a swift correction of more than 10% over the last six months….

Read More
Stocks to watch: TCS, Wipro, IRFC, Zydus Life, LIC Housing Fin among shares to remain in focus today | Stock Market News

Stocks to watch: TCS, Wipro, IRFC, Zydus Life, LIC Housing Fin among shares to remain in focus today | Stock Market News

Source: Live Mint Here’s a quick look at stocks likely to be in focus in today’s trade. Tata Consultancy Services IT services company TCS has collaborated with Vantage Towers, Europe’s second-largest telecom tower operator, to introduce a digital service platform. This partnership seeks to optimize service processes for property owners, improve retention, and reinforce telecom…

Read More
Stocks to watch: Biocon, Coforge, Adani Wilmar, Ola Electric, Power Grid among shares to remain in focus today | Stock Market News

Stocks to watch: Biocon, Coforge, Adani Wilmar, Ola Electric, Power Grid among shares to remain in focus today | Stock Market News

Source: Live Mint Here’s a quick look at stocks likely to be in focus in today’s trade. Biocon Biocon Pharma, a subsidiary of the company, has obtained final approval from the US Food and Drug Administration (US FDA) for two of its Abbreviated New Drug Applications (ANDAs) – Lenalidomide capsules and Dasatinib tablets. Lenalidomide is…

Read More
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 5 March 2025 | Stock Market News

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 5 March 2025 | Stock Market News

Source: Live Mint Breakout stocks to buy or sell: Indian frontline indices closed Tuesday’s trading session, March 4, in the red. The Nifty 50 dipped 0.17%, marking its 10th consecutive loss but managed to stay above the critical 22,000 level, settling at 22,082 points. Meanwhile, the Sensex slipped 0.13%, failing to sustain the 73,000 mark…

Read More
Stocks to watch: IRCTC, IRFC, RBL Bank, IEX, ASK Automotive, Paytm among shares to remain in focus today | Stock Market News

Stocks to watch: IRCTC, IRFC, RBL Bank, IEX, ASK Automotive, Paytm among shares to remain in focus today | Stock Market News

Source: Live Mint Here’s a quick look at stocks likely to be in focus in today’s trade. IRCTC, IRFC State-owned enterprises Indian Railway Catering and Tourism Corporation (IRCTC) and Indian Railway Finance Corporation (IRFC) were awarded ‘Navratna’ status by the Government of India on Monday, March 3. RBL Bank GST authorities conducted searches at three…

Read More
Stocks to watch: Tata Motors, Paytm, M&M, NLC India among shares to remain in focus today | Stock Market News

Stocks to watch: Tata Motors, Paytm, M&M, NLC India among shares to remain in focus today | Stock Market News

Source: Live Mint Here’s a quick look at stocks likely to be in focus in today’s trade. Tata Motors, Hyundai Motors, Maruti Maruti Suzuki recorded slight growth, whereas Hyundai and Tata Motors experienced a drop in sales in February, as market sluggishness persisted with subdued demand. Glenmark Pharma According to the US health regulator, Glenmark…

Read More